Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer

被引:1
作者
Marinova, Dora Marinova [1 ,2 ]
Mekov, Evgeni Vitkov [1 ,2 ]
Dimitrova, Denitsa Gosheva [1 ,2 ]
Titorenkov, Plamen Todorov [3 ]
Mihailov, Miroslav Martinov [1 ,2 ]
Nachev, Sevdalin Slavov [4 ]
Youroukova, Vania Milosheva [1 ,2 ]
Kostadinov, Dimitar Temelkov [1 ,5 ]
Slavova, Yanina Georgieva [1 ,6 ]
机构
[1] Med Univ, Clin Ctr Lung Dis, Sofia, Bulgaria
[2] Univ Hosp Pulm Dis St Sofia, Dept Pneumonol, Sofia, Bulgaria
[3] Sofia Univ, Mil Med Acad, Fac Med, Sofia, Bulgaria
[4] Univ Hosp St Ivan Rilski, Dept Pathol, Sofia, Bulgaria
[5] Univ Hosp Pulm Dis St Sofia, Dept Bronchol, Sofia, Bulgaria
[6] Univ Hosp Pulm Dis St Sofia, Dept Pathol, Sofia, Bulgaria
来源
JOURNAL OF BUON | 2019年 / 24卷 / 04期
关键词
brain metastases; immunohistochemistry; lung cancer; CELL CARCINOMA; SURVIVAL; PATTERN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study brain metastases (BM) and their corresponding primary lung cancers (LCs). Methods: Surgically resected BMs and their corresponding primary LCs from 30 patients (25 men, 83%, age 55 +/- 9 years) were studied: 21 adenocarcinomas (ACs), 5 squamous cell carcinomas (SCCs), 4 small cell lung carcinomas (SCLCs). The histological subtype, immunohistochemical expression of TTF1, p63, Ki67 (proliferative activity), CD31, number of intratumoral microvessels, (NIM) and survival were evaluated. Results: There was a different histological structure in 47% of the cases of ACs of the lung in comparison with the corresponding metastasis, but none in SCC and SCLC. TTF-1 was expressed in a greater number of ACs (n=20; 95%), with lower mean expression levels, while the corresponding BM expressed the marker less frequently (n=16; 76%) with higher mean expression values (p=0.011). P63 was expressed in all SCCs (p=0.68). Cytokeratin 7 was expressed equally in all ACs. Ki-67 proliferative index (PI) was higher in SCLC than in AC (p=0.008), in SCLC BM than in AC BM (p<0.001), and in SCLC BM than in SCC BM (p=0.008). The Ki-67 PI in BM was higher than in AC (p=0.003), SCC (p=0.048), but without difference in SCLC (p=0.141). CD31 NIM was higher in AC than in SCLC (p=0.003), in SCC than in SCLC (p=0.009), while no difference between AC and SCC was found (p=0.467). There were no differences between LC/BM in the NIM. Survival after surgery for LC was significantly longer in AC than in SCLC (p=0.017). SCLC histology and Ki67>18% were established as negative prognostic factors after surgery for LC. Such factors were not found after surgery for BM. Conclusion: There are differences between primary LC and corresponding BM - in histology, immunohistochemical expression and proliferative activity, but there are no significant differences in vascularization. SCLC histology and Ki67>8% may represent negative prognostic factors after surgery for LC with BM.
引用
收藏
页码:1626 / 1637
页数:12
相关论文
共 50 条
[31]   Lung cancer: atypical brain metastases mimicking neurocysticercosis [J].
Patrícia Caetano Mota ;
Carina Reis ;
Nuno Filipe Pires ;
Graça Sousa ;
Clara Chamadoira ;
Marcos Guimarães ;
Lígia Castro ;
Margarida Marques ;
Isabel Gomes .
International Journal of Clinical Oncology, 2011, 16 :746-750
[32]   Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling [J].
Higuchi, Rumi ;
Goto, Taichiro ;
Nakagomi, Takahiro ;
Hirotsu, Yosuke ;
Oyama, Toshio ;
Amemiya, Kenji ;
Mochizuki, Hitoshi ;
Omata, Masao .
JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (12)
[33]   Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary [J].
Drlicek, M ;
Bodenteich, A ;
Urbanits, S ;
Grisold, W .
PATHOLOGY RESEARCH AND PRACTICE, 2004, 200 (10) :727-734
[34]   Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases [J].
Bergen, E. S. ;
Scherleitner, P. ;
Ferreira, P. ;
Kiesel, B. ;
Mueller, C. ;
Widhalm, G. ;
Dieckmann, K. ;
Prager, G. ;
Preusser, M. ;
Berghoff, A. S. .
ESMO OPEN, 2021, 6 (03)
[35]   Brain metastases from colorectal cancer: characteristics and management [J].
Mege, Diane ;
Sans, Arnaud ;
Ouaissi, Mehdi ;
Iannelli, Antonio ;
Sielezneff, Igor .
ANZ JOURNAL OF SURGERY, 2018, 88 (03) :140-145
[36]   Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases [J].
Roussille, Pauline ;
Tachon, Gaelle ;
Villalva, Claire ;
Milin, Serge ;
Frouin, Eric ;
Godet, Julie ;
Berger, Antoine ;
Emambux, Sheik ;
Petropoulos, Christos ;
Wager, Michel ;
Karayan-Tapon, Lucie ;
Tougeron, David .
CANCERS, 2018, 10 (12)
[37]   Clinical characteristics and prognosis of lung metastases from unknown primary cancer sites [J].
Gao, Fuli ;
Liu, Luojie ;
Xu, Xiaodan .
ONCOLOGIE, 2024, 26 (05) :771-781
[38]   Magnetic resonance imaging characteristics of brain metastases in small cell lung cancer [J].
Zhu, Dan ;
Shao, Yongjia ;
Yang, Zhangwei ;
Cheng, Ailan ;
Xi, Qian ;
Liang, Xiaohua ;
Chu, Shuguang .
CANCER MEDICINE, 2023, 12 (14) :15199-15206
[39]   CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary [J].
Bachmann, C. ;
Grischke, E. M. ;
Fehm, T. ;
Staebler, A. ;
Schittenhelm, J. ;
Wallwiener, D. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) :551-556
[40]   Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer [J].
Failing, Jarrett J. ;
Aubry, Marie Christine ;
Mansfield, Aaron S. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) :215-219